Logo-ipp

Original

1. Association of serum total PSA level and free-to-total PSA ratio with grade of prostate cancer in biopsy specimens
Mohammad Yazdani, Azar Baradaran, Mohammad-Reza Tamadon, Samaneh Khodadadi, Majid Kabiri, Ali Mehrabi Koushki, Mahmoud Rafeian-Koopaie*
Immunopathol Persa. 2016;2(2): e21-.
Article
PDF
XML
Cited By:
Editorial

2. Vitamin D and cancer; a contradictory problem
Masoud Amiri*
Immunopathol Persa. 2018;4(2): e13. doi: 10.15171/ipp.2018.13
Article
PDF
XML
Cited By:
0
Original

3. New Gleason grade groups; epidemiologic data from Isfahan, Iran based on the new classification
Mohammad Yazdani* ORCID, Amir Salar Nourbakhsh ORCID, Amid Yazdani ORCID
Immunopathol Persa. 2022;8(2): e87. doi: 10.34172/ipp.2022.87
Scopus ID: 85133690935    
Article
PDF
XML
Cited By:
0
0
Original

4. Rate of clinically significant prostate cancer on repeated biopsy after a diagnosis of atypical small acinar proliferation
Mohammad Yazdani* ORCID, Payam Riahi Samani ORCID, Hamid Mazdak ORCID, Amid Yazdani ORCID
Immunopathol Persa. 2023;9(1): e94. doi: 10.34172/ipp.2022.94
Scopus ID: 85145910377    
Article
PDF
XML
Cited By:
1
0
Original

5. Evaluation of the urine mRNA-PCA3 expression level in prostate patients; comparison between benign prostatic hyperplasia and cancer
Amid Yazdani ORCID, Farshad Namdari, Sattar Gorgani-Firuzjaee, Hassan Niroomand* ORCID
Immunopathol Persa. 2022;8(2): e15207. doi: 10.34172/ipp.2022.15207
Scopus ID: 85133663177    
Article
PDF
XML
Cited By:
3
3

Meta-analysis

6. The association between systemic immune-inflammation index and risk of prostate carcinoma; a systematic review and meta-analysis
Atefeh Nourmohammadi ORCID, Sajad Ataei Azimi ORCID, Radhwan Abdul Kareem, Sarah Qutaiba Badraldeen ORCID, Rasoul Jafari Arismani ORCID, Roozbeh Roohinezhad ORCID, Hossein Pourmasomi ORCID, Armin Attar ORCID, Seyed Sohrab Vahdati* ORCID
Immunopathol Persa. 2025;. doi: 10.34172/ipp.2025.43810
Article
PDF
XML
Cited By: